How TASCENSO ODT works

TASCENSO ODT (orally disintegrating tablet) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.1

A diagram of Fingolimod blocks lymphocytes from leaving the lymph node.

Fingolimod blocks lymphocytes from leaving the lymph node.

Arrow pointing right
Diagram of reducing the number of lymphocytes in the blood. It is thought this may reduce lymphocyte migration into the central nervous system.

Reducing the number of lymphocytes in the blood. It is thought this may reduce lymphocyte migration into the central nervous system.

A diagram of Fingolimod blocks lymphocytes from leaving the lymph node.

Fingolimod blocks lymphocytes from leaving the lymph node.

Arrow pointing down
Diagram of reducing the number of lymphocytes in the blood. It is thought this may reduce lymphocyte migration into the central nervous system.

Reducing the number of lymphocytes in the blood. It is thought this may reduce lymphocyte migration into the central nervous system.

Read more about TASCENSO ODT
Get started with TASCENSO ODT

References

1. TASCENSO ODT (fingolimod). Prescribing Information. Cycle Pharmaceuticals Ltd.